Axodin Pharmaceuticals Private Limited, a active private limited company, was established on 11 July 2016 in Ambala City, Haryana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230HR2016PTC064965. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Darshana Devi (Director), Rahul Saini (Director). Past directors included Siri Ram. It holds ₹1.21 Cr open charges and ₹2.50 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 39/8/2, Markandey Complex Sena Nagar, P.O Dhulkot, Ambala City, Haryana, 134003.
U24230HR2016PTC064965
064965
11 July 2016
₹1.00 M
₹1.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Axodin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Darshana Devi | Director | 25 Jul 2016 | Current |
| Rahul Saini | Director | 11 Jul 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Aug 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Axodin Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.51% increase. The company also saw a slight improvement in profitability, with a 7.63% increase in profit. The company's net worth Soared by an impressive increase of 20.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Axodin Pharmaceuticals had a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,090,900.00
₹2,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2022 | Hdfc Bank Limited | ₹2.09 M | Open |
| 01 Jul 2020 | Hdfc Bank Limited | ₹1.00 Cr | Open |
| 12 Oct 2016 | Others | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Axodin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Axodin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axodin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Axodin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Axodin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
A charge with Hdfc Bank Limited of Rs. 10.00 M registered on 01 Jul 2020 with Charge ID 100369944 was modified on 07 Sep 2023. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.09 M with Charge ID 100656904 was registered on 05 Dec 2022. was documented.
The activity A charge registered on 12 Oct 2016 via Charge ID 100057670 with Others was fully satisfied on 07 Jul 2020. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 10.00 M with Charge ID 100369944 was registered on 01 Jul 2020. was documented.
The CIN of Axodin Pharmaceuticals Private Limited is U24230HR2016PTC064965.
Axodin Pharmaceuticals Private Limited is headquartered at 39/8/2, Markandey Complex Sena Nagar, P.O Dhulkot, Ambala City, Haryana, 134003.
Axodin Pharmaceuticals Private Limited was incorporated on 11 July 2016.
The current directors of Axodin Pharmaceuticals Private Limited are
The primary industry of Axodin Pharmaceuticals Private Limited is Trade.
Axodin Pharmaceuticals Private Limited is unlisted.
The authorized capital of Axodin Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Axodin Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX